Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
82.62
+0.25 (0.30%)
Oct 12, 2026, 10:48 AM EDT - Market open
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $4.62 billion as of October 12, 2026. It is the 3,885th most valuable company in the world and the 1,220th biggest in the United States. Its market cap has increased by 236.81% in one year.
Market Cap
4.62B
Enterprise Value
3.43B
1-Year Change
236.81%
Global Rank
Country Rank
#1,220 United States
Category
ChartMarket Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $4.62B, an increase of 2,735.24%. That is a compound annual growth rate of 195.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 4.62B | 161.55% |
| Dec 31, 2025 | 1.77B | 173.85% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
| Sep 12, 2023 | 162.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oruka Therapeutics | 5.44B |
| PTC Therapeutics | 5.40B |
| Cogent Biosciences | 5.38B |
| CRISPR Therapeutics AG | 5.16B |
| Scholar Rock Holding | 5.14B |
| Definium Therapeutics | 4.96B |
| Travere Therapeutics | 4.91B |
| Edgewise Therapeutics | 4.24B |